PAPER Jaiswal A, Mishra S, Dwivedi PK, Verma S

SERS-Based Microfluidic Bioscreening Platform for Selective Detection of β-Amyloid Peptides.

Langmuir. 2024 Nov 19;40(46):24463-24470. Epub 2024 Nov 8 PubMed.

PAPER Pelkmans W, Gispert JD

Astroglial reactivity is a key modulator of Alzheimer's disease pathological progression.

Brain. 2024 Nov 8; Epub 2024 Nov 8 PubMed.

PAPER Tong J, Li C, Zhao J, Wang K, Zhao Z, Liu Y, Qing T, Liu X

Poly-Adenine Assisted Signaling Displaced Probe Ratiometric Electrochemical Aptasensor for Accurate Detection of Alzheimer's Disease Aβ Biomarkers.

ACS Appl Mater Interfaces. 2024 Nov 20;16(46):64297-64306. Epub 2024 Nov 8 PubMed.

PAPER Brolin KA, Bäckström D, Wallenius J, Gan-Or Z, Puschmann A, Hansson O, Swanberg M

GBA1 T369M and Parkinson's disease- Further evidence of a lack of association in the Swedish population.

Parkinsonism Relat Disord. 2024 Oct 31;130:107191. Epub 2024 Oct 31 PubMed.

PAPER Oh CK, Nakamura T, Zhang X, Lipton SA

Redox regulation, protein S-nitrosylation, and synapse loss in Alzheimer's and related dementias.

Neuron. 2024 Nov 5; Epub 2024 Nov 5 PubMed.

PAPER Wang L, Hu W, Wang H, Song Z, Lin H, Jiang J

Different stimulation targets of rTMS modulate specific triple-network and hippocampal-cortex functional connectivity.

Brain Stimul. 2024 Nov 7;17(6):1256-1264. Epub 2024 Nov 7 PubMed.

PAPER Das A, Rajput V, Chowdhury D, Choudhary R, Bodakhe SH

Boron: An intriguing factor in retarding Alzheimer's progression.

Neurochem Int. 2024 Nov 6;181:105897. Epub 2024 Nov 6 PubMed.

PAPER Alrouji M, Anwar S, Venkatesan K, Shahwan M, Hassan MI, Islam A, Shamsi A

Iron homeostasis and neurodegeneration in the ageing brain: Insight into ferroptosis pathways.

Ageing Res Rev. 2024 Nov 7;102:102575. Epub 2024 Nov 7 PubMed.

PAPER Sharma K, Rai P, Tapadia MG

Impaired insulin signaling and diet-induced type 3 diabetes pathophysiology increase amyloid β expression in the Drosophila model of Alzheimer's disease.

Biochim Biophys Acta Mol Cell Res. 2024 Nov 7;1872(1):119875. Epub 2024 Nov 7 PubMed.

PAPER Suárez-González A, Bier N, Sauvageau H, Pelak VS, Ahmed S

Cognitive rehabilitation in posterior cortical atrophy.

Pract Neurol. 2024 Nov 7; Epub 2024 Nov 7 PubMed.

PAPER Mahase E

Alzheimer's disease: What treatments could be rolled out in the next few years?

BMJ. 2024 Nov 8;387:q2477. PubMed.

PAPER Li M, Ping W, Dai Q, Xu J

Can lecanemab bring hope to people with Alzheimer's disease?

Asian J Surg. 2024 Nov 8; Epub 2024 Nov 8 PubMed.

PAPER Blankenship HE, Carter KA, Pham KD, Cassidy NT, Markiewicz AN, Thellmann MI, Sharpe AL, Freeman WM, Beckstead MJ

VTA dopamine neurons are hyperexcitable in 3xTg-AD mice due to casein kinase 2-dependent SK channel dysfunction.

Nat Commun. 2024 Nov 8;15(1):9673. PubMed.

PAPER Yao Q, Mañas A, Beatty E, Dos Santos AC, Zhou Y, Juárez O, Chen H, Xiang J

Alternative production of pro-death Bax∆2 protein via ribosomal frameshift in Alzheimer's disease.

Sci Rep. 2024 Nov 8;14(1):27288. PubMed.

PAPER Nabizadeh F, Seyedmirzaei H, Karami S

Author Correction: Neuroimaging biomarkers and CSF sTREM2 levels in Alzheimer's disease: a longitudinal study.

Sci Rep. 2024 Nov 8;14(1):27218. PubMed. Corrected paper.